Mitsubishi Research Institute Inc. (MRI) and Astellas Pharma Inc. have agreed on a memorandum of understanding to provide drug-discovery startups in Japan with support in their efforts to go global. The pair aims to strengthen Japan’s position as a global hub for drug discovery and foster the growth of its startups that can thrive globally. The new support represents multiple programs under the Ministry of Health, Labour and Welfare’s Medical Innovation Support Office (MEDISO), wh...